BridgeMD
New treatment option for Malignant Tumor of Soft Tissue of Head, Face and Neck
Official title Acupuncture as the Therapeutic Modalities of Acute Toxicity in the Radiotherapy of Head and Neck Tumors
ClinicalTrials.gov ID: NCT03751566
What this study is testing
What is Standard supportive therapy?
Standard supportive therapy is an investigational medicine, being studied as a potential treatment for malignant tumor of soft tissue of head, face and neck.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- The aim of the study is to evaluate the benefit of the acupuncture as healing modalities in the therapy of acute toxicity of radiotherapy.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Curative and adjuvant radiotherapy for head and neck tumors;
- PS 1-2;
- Patient collaboration in evaluation of the toxicity diary.
You likely can't join if
- Palliative radiotherapy in the head and neck tumor;
- PS 3;
- Non-compliance of the patient.
The study team makes the final eligibility decision.
Where it's taking place
- Brno, Czechia
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Brno, Czechia. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.